548
Views
18
CrossRef citations to date
0
Altmetric
CLINICAL STUDY

Low Dose Intravenous Ascorbic Acid for Erythropoietin-Hyporesponsive Anemia in Diabetic Hemodialysis Patients with Iron Overload

, M.D., , &
Pages 445-453 | Published online: 26 Aug 2009

References

  • Sunder-Plassmann G., Horl W.H. Erythropoietin and iron. Clin. Nephrol. Mar. 1997; 47(3)141–157
  • Bridges K.R., Hoffman K.E. The effects of ascorbic acid on the intracellular metabolism of iron and ferritin. J. Biol. Chem. Oct. 25 1986; 261(30)14273–14277
  • Lipschitz D.A., Bothwell T.H., Seftel H.C., Wapnick A.A., Charlton R.W. The role of ascorbic acid in the metabolism of storage iron. Br. J. Hematol. Feb. 1971; 20(2)155–163
  • Tarng D.C., Wei Y.H., Huang T.P., Kuo B.I., Yang W.C. Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia. Kidney Int. Jun. 1999; 55(6)2477–2486
  • Wu M.S., Yu C.C., Yang C.W., Wu C.H., Haung J.Y., Hong J.J., Fan Chiang C.Y., Huang C.C., Leu M.L. Poor pre-dialysis glycemic control is a predictor of mortality in type II diabetic patients on maintenance hemodialysis. Nephrol. Dial. Transplant 1997; 12: 2105–2110
  • Ha H., Kim K.H. Role of oxidative stress in the development of diabetic nephropathy. Kidney Int. Suppl. Sep. 1995; 51: S18–S21
  • Eckardt K.U. Pathophysiology of renal anemia. Clin. Nephrol. Feb. 2000; 53(1 suppl)S2–S8
  • Oostenbrug G.S., Mensink R.P., Hardeman M.R., De Vries T., Brouns F., Hornstra G. Exercise performance, red blood cell deformability, and lipid peroxidation: effects of fish oil and vitamin E. J. Appl. Physiol. Sep. 1997; 83(3)746–752
  • Craven P.A., DeRubertis F.R., Kagan V.E., Melhem M., Studer R.K. Effects of supplementation with vitamin C or E on albuminuria, glomerular TGF-beta, and glomerular size in diabetes. J. Am. Soc. Nephrol. Sep. 1997; 8(9)1405–1414
  • Kerr P.B., Argiles A., Flavier J.L. Comparison of hemodialysis and hemodiafiltration: a long-term longitudinal study. Kidney Int. 1992; 41: 1035–1040
  • Tarng D.C., Huang T.P. A parallel, comparative study of intravenous iron versus intravenous ascorbic acid for erythropoietin-hyporesponsive anaemia in hemodialysis patients with iron overload. Nephrol. Dial. Transplant Nov. 1998; 13(11)2867–2872
  • Sullivan J.F., Eisenstein A.B. Ascorbic acid depletion in patients undergoing chronic hemodialysis. Am. J. Clin. Nutr. Oct. 1970; 23(10)1339–1346
  • Alkhunaizi A.M., Chan L. Secondary oxalosis: a cause of delayed recovery of renal function in the setting of acute renal failure. J. Am. Soc. Nephrol. Nov. 1996; 7(11)2320–2326
  • Descombes E., Hanck A.B., Fellay G. Water soluble vitamins in chronic hemodialysis patients and need for supplementation. Kidney Int. Jun. 1993; 43(6)1319–1328
  • Cotton A.B. Routines vitamin therapy for the dialysis therapy: current concerns. Contemp. Dial. Nephrol. 1995; 16: 26–27
  • Costello J.F., Sadovnic M.J., Cottington E.M. Plasma oxalate levels rise in hemodialysis patients despite increased oxalate removal. J. Am. Soc. Nephrol. Jun. 1991; 1(12)1289–1298
  • Nienhuis A.W., Delea C., Aamodt R., Bartter F., Anderson W.F. Evaluation of desferrioxamine and ascorbic acid for the treatment of chronic iron overload. Birth Defects Orig. Artic. Ser. 1976; 12(8)177–185

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.